- Half Year 2023 Genfit SA Earnings Call TranscriptSep 20, 2023$3.8Earnings
- Genfit SA and Ipsen SA Announce Positive Results from Phase III ELATIVE® Trial of Elafibranor in Patients with Primary Biliary Cholangitis Call TranscriptJun 30, 2023
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 14, 2023$4.39Earnings
- Genfit SA to Acquire Clinical-Stage Biopharmaceutical Company Versantis AG Call TranscriptSep 19, 2022
- Full Year 2022 Genfit SA Earnings Call TranscriptApr 08, 2022$5Earnings
- Genfit SA Corporate Call TranscriptDec 17, 2021
- Half Year 2021 Genfit SA Earnings Call TranscriptSep 29, 2021$3.71Earnings
- Genfit SA Updates On Pipeline TranscriptMay 11, 2021
- Full Year 2020 Genfit SA Earnings Presentation TranscriptApr 01, 2021
- Half Year 2020 Genfit SA Earnings Call (English) TranscriptSep 30, 2020$5.62 (+0.90%)Earnings
- Q4 2019 Genfit SA Earnings Call TranscriptApr 09, 2020$15.84 (-2.34%)Earnings
Q4 2019 Genfit SA Earnings Call Transcript
Greetings, and welcome to Genfit Reports 2019 Year-end Financial Results and Corporate Update Conference call. (Operator Instructions) It's now my pleasure to introduce your host, Naomi Eichenbaum. Please go ahead.
Thank you. Good morning, everyone, and thank you for joining us on Genfit's full year 2019 financial results and corporate update conference call. Last night, we issued a press release with the updated 2019 financial figures and corporate updates which can be accessed on our website at ir.genfit.com.
Prior to beginning, I would like to note that during our call, we will be making forward-looking statements. This webcast contains certain forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995 with respect to Genfit, our expected future performance, business prospects, financial guidance, events or plans, including timing of the announcement of the top line interim results of our Phase III RESOLVE-IT clinical trials, timing of our NDA submission for elafibranor in
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)